MARK RYBAKOV: Open Payments
NPI 1295037620 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$638 in 27 payments from 8 companies in 2025. Trend: 2023 $298 · 2024 $677 · 2025 $638
Food & beverage: $638
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 11 | $233 |
| Axsome Therapeutics, Inc. | 7 | $171 |
| Vanda Pharmaceuticals Inc. | 2 | $61 |
| ViiV Healthcare Company | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Almatica Pharma LLC | 1 | $31 |
| Bausch Health US, LLC | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
Products named: REXULTI, Auvelity, FANAPT, APRETUDE, LOREEV XR, WELLBUTRIN, XTAMPZA.
Industry payments across NY — which companies pay providers there.
